No abstract available
MeSH terms
-
Aged
-
Benzamides / therapeutic use*
-
Female
-
Humans
-
Imatinib Mesylate
-
Maintenance Chemotherapy / methods
-
Male
-
Middle Aged
-
Piperazines / therapeutic use*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrimidines / therapeutic use*
-
Remission Induction
-
Time Factors
-
Treatment Outcome
Substances
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate